Watch IAM. Know when insiders buy.
One email the day a filing lands. Free.
IAM
Iambic Therapeutics, Inc.
16.34
−7.47 −31.37%
USD · close Oct 19
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
80
PASS · insiders 80
Insiders, 90 days
+$11.5M
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 16.34 – 23.81
Who holds it
None of the 15 tracked funds disclose IAM in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on IAM in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.